| Dr Jeffrey Robbins Goldbarg, MD | |
|
14 Vernon St, Ste 206, Framingham, MA 01701-4783 | |
| (508) 626-0076 | |
| (508) 626-0546 |
| Full Name | Dr Jeffrey Robbins Goldbarg |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 14 Vernon St, Framingham, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649213943 | NPI | - | NPPES |
| 38283 | Other | MA LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 38283 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Robbins Goldbarg, MD 14 Vernon St, Ste 206, Framingham, MA 01701-4783 Ph: (508) 626-0076 | Dr Jeffrey Robbins Goldbarg, MD 14 Vernon St, Ste 206, Framingham, MA 01701-4783 Ph: (508) 626-0076 |
News Archive
Genentech, Inc. a wholly owned member of the Roche Group, and Biogen Idec announced today a Phase III study (STAGE) of the investigational humanized anti-CD20 monoclonal antibody ocrelizumab given in combination with methotrexate (MTX) met its primary endpoint of improving signs and symptoms (as measured by American College of Rheumatology or ACR20 response) in rheumatoid arthritis (RA) patients who had an inadequate response to MTX at both 24 and 48 weeks.
According to new research that will be presented on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, the majority of U.S. dental schools have not adequately prepared their graduates to screen for sleep disorders, which affect more than 70 million adults in the U.S.
What makes cancer so deadly is its ability to move . The better that doctors can keep tumors contained and protect unaffected organs in the body, the less lethal a cancer will be.
In its most recent annual report, the President's Cancer Panel lists in-home water filtration as a way to decrease exposure to both known and suspected carcinogens as well as endocrine disruptors. Kinetico's line of in-home treatment options provides multiple resources for water filtration, in line with the PCP's recommended solution to lower in-home exposure to carcinogens.
Discovery Laboratories, Inc. today announces that the Phase 2a clinical study of aerosolized KL4 surfactant (lucinactant) in patients with cystic fibrosis (CF) has completed and the results from the study will be presented at the upcoming North American Cystic Fibrosis Conference (NACFC; October 21-23, 2010).
› Verified 6 days ago
Joseph G. D'alton, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 463 Worcester Rd, Suite 101, Framingham, MA 01701 Phone: 508-820-0469 Fax: 508-626-1985 | |
Adriana Neagoe, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 945 Concord St, Framingham, MA 01701 Phone: 508-283-7898 Fax: 508-764-2462 | |
Ashley Lee Shepard, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 600 Worcester Rd Ste 201, Framingham, MA 01702 Phone: 508-845-1110 | |
Dr. Sean Orin Mackintosh, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Frederick Abbott Way, Framingham, MA 01701 Phone: 508-879-9800 Fax: 508-875-1348 | |
Dr. James Allen Kennedy, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 88 Lincoln St, Framingham, MA 01702 Phone: 508-879-9800 | |
Robert Merle Johnston, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 354 Waverly St, Advocates Inc., Framingham, MA 01702 Phone: 508-661-2020 | |
Dr. Jacob Goldberg, D.O. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 359 Union Ave, Framingham, MA 01702 Phone: 508-620-1919 Fax: 508-820-3093 |